Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 28 Mar 2017 for BioPharma Credit PLC, €92k.
Filing timeline
BuySaleDuncan Budge
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +0.1%Entry US$1.03 · Close at T+365 US$1.03
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Duncan Budge: trading record in brief
Only one filing by Duncan Budge is known so far (28 March 2017): an open-market purchase, €92k, in BioPharma Credit PLC. That is too little to draw conclusions. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Duncan Budge
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 100,000 shares@ US$1.00100.0% of flowLondon Stock Exchange (XLON)ISIN GB00BDGKMY29FCA-NSM:LSE20170328103001_13173892_20200330131526717_22286Canonical exit: 25 Jun 2017 (T+90)
1 of 1 declaration